New survey reveals Canadians are largely unaware about osteoporosis and the serious consequences it can have on their health TORONTO, ON (February 2, 2016) – Snow and ice can make walking […]

Medications that can Cause Bone Loss, Falls and/or Fractures A variety of medications can increase bone loss and/or fall risk: Synthetic Glucocorticoids (e.g. Prednisone) Glucocorticoids are produced naturally by the […]

Managing Pain You may or may not experience pain with a diagnosis of osteoporosis. There are several reasons why an individual with osteoporosis might experience pain: As described above, fractures […]

VIDEO SERIES ON EXERCISE AND OSTEOPOROSIS Osteoporosis Canada has developed a video series on exercise and osteoporosis in partnership with the University of Waterloo and Geriatric Education and Research in […]

About Us Educate, empower and support Who Are We Osteoporosis Canada is the only national organization serving people affected by osteoporosis. The organization works to educate, empower and support individuals […]

Denosumab A human monoclonal antibody that prevents RANKL-RANK interaction Denosumab (Bone Metabolism Regulator) Denosumab is a new class of osteoporosis treatment called a human monoclonal antibody that prevents RANKL-RANK interaction […]

Zoe Bond, Dana Li and Rebecca Wills Diabetes and Fracture Risk Diabetes mellitus, commonly known as diabetes, is a condition that affects the hormone insulin, resulting in high blood sugar […]

The International Society for Clinical Densitometry (ISCD) Researcher of the Year award for 2020 was recently presented to Dr. William D. Leslie, MD, FRCPC, MSc, CCD. This award is given to […]

PARATHYROID HORMONE (PTH) A new class of osteoporosis treatments called bone formation agents Parathyroid hormone analogues belong to a class of osteoporosis medications which can promote bone growth. In Canada, […]